Heart Disease And Stroke Statistics—2014 Update
Most cardiovascular disease (CVD) is complex, with genetic, environmental, and epigenetic factors influencing disease progression.
The rapid progression of genomic technologies has greatly expanded our knowledge of CVDs and stroke over the last several years.
Continued research and education are necessary to facilitate the translation of genomic discoveries to clinical practice.
Read the full article in
. 2014: published online December 18, 2013, 10.1161/01.cir.0000441139.02102.80.
Top Ten Things To Know
AHA Statements and Guideline Library
AHA Heart Disease & Stroke Statistics Home
My American Heart for Professionals
You're the Cure
AHA Science News Home
Genome-Wide Analysis of Blood Pressure Variability and Ischemic Stroke
. 2013; 44: 2703-2709 Published online before print August 8, 2013, doi: 10.1161/?STROKEAHA.113.002186
Genetic Architecture of Carotid Artery Intima-Media Thickness in Mexican Americans
: Cardiovascular Genetics. 2013; 6: 211-221 Published online before print March 13, 2013, doi: 10.1161/?CIRCGENETICS.113.000079
“Good Enough Solutions” and the Genetics of Complex Diseases
. 2012; 111: 493-504 doi: 10.1161/?CIRCRESAHA.112.269084
Genetics and Cardiovascular Disease: A Policy Statement From the American Heart Association
. 2012; 126: 142-157 Published online before print May 29, 2012, doi: 10.1161/?CIR.0b013e31825b07f8
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
. 2007; 115: 2878-2901 Published online before print May 21, 2007, doi: 10.1161/?CIRCULATIONAHA.107.183679
on Dec 18, 2013 3:30 PM America/Chicago
Leave a Comment
to post a comment.
Powered by Small World Community